Movano Inc. (MOVE): Price and Financial Metrics
MOVE Price/Volume Stats
| Current price | $1.04 | 52-week high | $3.24 |
| Prev. close | $1.02 | 52-week low | $0.90 |
| Day low | $0.99 | Volume | 10,700 |
| Day high | $1.05 | Avg. volume | 55,747 |
| 50-day MA | $1.13 | Dividend yield | N/A |
| 200-day MA | $1.78 | Market Cap | 43.08M |
MOVE Stock Price Chart Interactive Chart >
Movano Inc. (MOVE) Company Bio
Movano Inc., a technology company, develops a smart wearable and continuous glucose monitoring device. Its device enables individuals and their healthcare partners to measure and manage their health conditions. Movano Inc. was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. The company was incorporated in 2018 and is based in Pleasanton, California.
Latest MOVE News From Around the Web
Below are the latest news stories about MOVANO INC that investors may wish to consider to help them evaluate MOVE as an investment opportunity.
Movano Health Provides Business Update and Reports First Quarter 2023 Financial ResultsToday, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, reported financial results for the three months ending March 31, 2023 and provided a business update. |
Movano Inc. to Report First Quarter 2023 Financial Results on Monday, May 15, 2023Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report first quarter 2023 financial and operating results on Monday, May 15, 2023. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 9:00 a.m. PDT (12:00 p.m. EDT). |
Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial ResultsToday, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, reported financial results for the three months and year ending December 31, 2022 and provided a business update. |
Movano Health Awarded Three New Core Patents Validating its Cutting-Edge Approach to Radio Frequency-Enabled Glucose and Blood Pressure MonitoringMovano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, has been granted three new patents (2 US; 1 China) further safeguarding the Company's systems and methods for radio frequency-enabled health monitoring with specific protection for health parameters of blood glucose levels, blood pressure and heart rate. These new patents extend Movano Health's growing IP portfolio to 21 patents issued and 3 |
What Women Want: Accuracy is Critical to Future Wearable UseMovano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, announces the results of their study of opportunities within the wearables market. The results speak clearly to accuracy being a major factor for women considering a wearable device. |
MOVE Price Returns
| 1-mo | -4.59% |
| 3-mo | -23.53% |
| 6-mo | -40.57% |
| 1-year | -52.73% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -20.00% |
| 2022 | -65.79% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...